Intravitreal autologous plasmin as a therapeutic modality for diffuse diabetic macular edema
{{output}}
Objectives: To evaluate the outcome of vitreolysis using intravitreal autologous plasmin (IAP) injection as a sole therapeutic modality for patients with diffuse diabetic macular edema in comparison to triamcinolone acetonide (TA... ...
